NursingDrugGuide.com
         Wolters Kluwer | Lippincott Williams & Wilkins

Lippincott's Nursing Drug Guide













        
bevacizumab
Avastin Pharmaceutical company:
Genentech
www.gene.com

NEW INDICATION & DOSAGE
Metastatic renal cell carcinoma—
Adults: 10 mg/kg as I.V. infusion every 2 weeks in combination with interferon alfa. Infuse first infusion over 90 minutes; if first infusion is tolerated, administer second infusion over 60 minutes; all subsequent infusions can be given over 30 minutes if infusion over 60 minutes is tolerated.









Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins,
publisher of Lippincott's Nursing Drug Guide.
For help on how you should use this site, see our
Disclaimer.

© Copyright 2010 by Lippincott Williams & Wilkins